Annual report pursuant to Section 13 and 15(d)

Note 6 - Other Assets

v3.20.2
Note 6 - Other Assets
12 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Other Assets Disclosure [Text Block]
6.
Other Assets
 
The Corporation owns a reserve of krill oil in which amounts are expensed as it is used. The following table summarizes information regarding activities of amounts of the krill oil usage in the research and development production processes and for
NKPL66
(the active pharmaceutical ingredient for CaPre) manufacturing.
 
    March 31, 2020     March 31, 2019  
    $     $  
Balance – beginning of year    
466
     
513
 
Purchased    
312
     
53
 
Used    
(90
)    
(79
)
Foreign exchange- translation effect    
(20
)    
(21
)
Balance – end of year    
668
     
466
 
 
Current-other asset
   
195
     
49
 
Other asset    
473
     
417